145 related articles for article (PubMed ID: 37361157)
1. Effect of the "universal test and treat" policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda.
Mugenyi L; Hansen CH; Mayaud P; Seeley J; Newton R; Nanfuka M; Abaasa A; Mugisha K; Etukoit M; Kaleebu P; Ruzagira E
Front Public Health; 2023; 11():1187274. PubMed ID: 37361157
[TBL] [Abstract][Full Text] [Related]
2. Effect of universal test and treat on retention and mortality among people living with HIV-infection in Uganda: An interrupted time series analysis.
Mugenyi L; Nanfuka M; Byawaka J; Agaba C; Mijumbi A; Kagimu D; Mugisha K; Shabbar J; Etukoit M
PLoS One; 2022; 17(5):e0268226. PubMed ID: 35580126
[TBL] [Abstract][Full Text] [Related]
3. Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study.
Onoya D; Sineke T; Hendrickson C; Mokhele I; Maskew M; Long LC; Fox M
BMJ Open; 2020 Mar; 10(3):e030228. PubMed ID: 32213514
[TBL] [Abstract][Full Text] [Related]
4. Twelve months antiretroviral therapy retention among clients newly enrolled to care and treatment services in Geita Regin, Tanzania: does universal test and treat matter?
Masuke R; Kihaga Y; Mashala M; Ndalio S; Sukari O; Panga O
Pan Afr Med J; 2023; 46():20. PubMed ID: 38035160
[TBL] [Abstract][Full Text] [Related]
5. Effects of implementing universal and rapid HIV treatment on initiation of antiretroviral therapy and retention in care in Zambia: a natural experiment using regression discontinuity.
Mody A; Sikazwe I; Namwase AS; Wa Mwanza M; Savory T; Mwila A; Mulenga L; Herce ME; Mweebo K; Somwe P; Eshun-Wilson I; Sikombe K; Beres LK; Pry J; Holmes CB; Bolton-Moore C; Geng EH
Lancet HIV; 2021 Dec; 8(12):e755-e765. PubMed ID: 34656208
[TBL] [Abstract][Full Text] [Related]
6. Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.
Onoya D; Hendrickson C; Sineke T; Maskew M; Long L; Bor J; Fox MP
J Int AIDS Soc; 2021 Feb; 24(2):e25652. PubMed ID: 33605061
[TBL] [Abstract][Full Text] [Related]
7. CD4+ T-Cell Count at Antiretroviral Therapy Initiation in the "Treat-All" Era in Rural South Africa: An Interrupted Time Series Analysis.
Yapa HM; Kim HY; Petoumenos K; Post FA; Jiamsakul A; De Neve JW; Tanser F; Iwuji C; Baisley K; Shahmanesh M; Pillay D; Siedner MJ; Bärnighausen T; Bor J
Clin Infect Dis; 2022 Apr; 74(8):1350-1359. PubMed ID: 34309633
[TBL] [Abstract][Full Text] [Related]
8. Retention on antiretroviral therapy during Universal Test and Treat implementation in Zomba district, Malawi: a retrospective cohort study.
Alhaj M; Amberbir A; Singogo E; Banda V; van Lettow M; Matengeni A; Kawalazira G; Theu J; Jagriti MR; Chan AK; van Oosterhout JJ
J Int AIDS Soc; 2019 Feb; 22(2):e25239. PubMed ID: 30734510
[TBL] [Abstract][Full Text] [Related]
9. The effect of the Universal Test and Treat policy uptake on CD4 count testing and incidence of opportunistic infections among people living with HIV infection in Cameroon: a retrospective analysis of routine data.
Bekolo CE; Ndeso SA; Gougue CP; Moifo LL; Mangala N; Tchendjou P; Mboh E; Ateudjieu J; Tendongfor N; Nsagha DS; Halle-Ekane GE; Choukem SP
Dialogues Health; 2023 Dec; 2():100120. PubMed ID: 38515498
[TBL] [Abstract][Full Text] [Related]
10. Motivating people living with HIV to initiate antiretroviral treatment outside national guidelines in three clinics in the HPTN 071 (PopART) trial, South Africa.
Mubekapi-Musadaidzwa C; Wademan D; Peton N; Hendricks P; Carolus G; Mbaezue R; Kelley KF; Kruger J; Jennings K; Grobbelaar N; Louis F; Beyers N; Ayles H; Fidler S; Hayes R; Bock P; Hoddinott G
Afr J AIDS Res; 2021 Mar; 20(1):32-41. PubMed ID: 33635735
[No Abstract] [Full Text] [Related]
11. Timing and Predictors of Initiation on Antiretroviral Therapy Among Newly-Diagnosed HIV-Infected Persons in South Africa.
Larsen A; Cheyip M; Tesfay A; Vranken P; Fomundam H; Wutoh A; Aynalem G
AIDS Behav; 2019 Feb; 23(2):375-385. PubMed ID: 30008050
[TBL] [Abstract][Full Text] [Related]
12. Universal test and treat in Cameroon: a comparative retrospective analysis of mortality and loss to follow-up before and after a strategic change in approach to HIV care.
Bekolo CE; Ndeso SA; Moifo LL; Mangala N; Yimdjo TD; Ateudjieu J; Kouanfack C; Djam A; Tabah EN; Whegang S; Mapa-Tassou C; Tendongfor N; Nsagha DS; Choukem SP
Pan Afr Med J; 2023; 45():191. PubMed ID: 38020352
[TBL] [Abstract][Full Text] [Related]
13. Lost to follow up rate in the first year of ART in adults initiated in a universal test and treat programme: a retrospective cohort study in Ekurhuleni District, South Africa.
Chauke P; Huma M; Madiba S
Pan Afr Med J; 2020; 37():198. PubMed ID: 33505567
[TBL] [Abstract][Full Text] [Related]
14. Evidence of reduced treatment adherence among HIV infected paediatric and adolescent populations in Nairobi at the onset of the UNAIDS Universal Test and Treat Program.
Kabogo J; Muniu E; Wamunyokoli F; Musoke R; Songok E
BMC Res Notes; 2018 Feb; 11(1):134. PubMed ID: 29452597
[TBL] [Abstract][Full Text] [Related]
15. Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study.
Kiyingi M; Nankabirwa JI; Sekaggya-Wiltshire C; Nangendo J; Kiweewa JM; Katahoire AR; Semitala FC
BMC Health Serv Res; 2023 Jan; 23(1):40. PubMed ID: 36647104
[TBL] [Abstract][Full Text] [Related]
16. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
17. HIV viral load suppression among people with mental disorders at two urban HIV clinics in Uganda: a parallel convergent mixed methods study using the social ecological model.
Ndagire R; Wangi RN; Ojiambo KO; Nangendo J; Nakku J; Muyinda H; Semitala FC
AIDS Res Ther; 2023 Sep; 20(1):68. PubMed ID: 37726822
[TBL] [Abstract][Full Text] [Related]
18. HIV Treatment Outcomes Among Patients Initiated on Antiretroviral Therapy Pre and Post-Universal Test and Treat Guidelines in South Africa.
Hirasen K; Fox MP; Hendrickson CJ; Sineke T; Onoya D
Ther Clin Risk Manag; 2020; 16():169-180. PubMed ID: 32184609
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.
Okoboi S; Ssali L; Yansaneh AI; Bakanda C; Birungi J; Nantume S; Okullu JL; Sharp AR; Moore DM; Kalibala S
J Int AIDS Soc; 2016; 19(5 Suppl 4):20841. PubMed ID: 27443271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
